Coronary artery aneurysm
Coronary artery dilatation occurs locally or diffusely, more than twice the original diameter of the local area, presenting single or multiple tumor-like changes, which is called coronary artery aneurysm. Both congenital and acquired conditions can form coronary artery aneurysms.
-
Site of disease:
Heart blood vessels -
Infectious :
Not contagious -
Frequent population:
Mostly occurs in people over 50 years old -
Related symptoms:
High fever dissection hematoma hand and foot peeling swollen lymph nodes in the neck high fever -
Concurrent disease:
Related Drugs
Tranexamic Acid for Injection
Indication: This product is mainly used for various bleeding caused by acute or chronic, localized or systemic primary hyperfibrinolysis. This product is generally not used for secondary hyperfibrinolytic state caused by disseminated intravascular coagulation before heparinization. This product is also suitable for: 1. Traumatic or surgical bleeding in organs rich in plasminogen activators such as the prostate, urethra, lungs, brain, uterus, adrenal glands, and thyroid glands. 2. Used as an antagonist of tissue plasminogen activator (t-PA), streptokinase, and urokinase. 3. Fibrinolytic bleeding caused by artificial abortion, early placental abruption, stillbirth, and amniotic fluid embolism. 4. Pathologically increased local fibrinolysis in the uterine cavity, menorrhagia, and anterior chamber
Manufacturer:
Zhejiang Jinhua Conba BIO-PHARM. Co., Ltd.
Related Ingredients
-
Tranexamic Acid list
1197-18-8 -
(1r,4r)-4-(formamidomethyl)cyclohexane-1-carboxylic acid list
1599413-49-6